Treatment of acquired perforating dermatosis with cantharidin.

Archives of dermatology 20120201

'Alternately divided' epidermal nevus of the fingers.

Pediatric dermatology 20120101

PGC-1α induces mitochondrial and myokine transcriptional programs and lipid droplet and glycogen accumulation in cultured human skeletal muscle cells.

PloS one 20120101

Genome-wide RNAi screen in IFN-γ-treated human macrophages identifies genes mediating resistance to the intracellular pathogen Francisella tularensis.

PloS one 20120101

DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.

PloS one 20120101

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.

Cancer management and research 20120101

Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.

European journal of medical research 20120101

Use of topical tretinoin and the development of noncutaneous adverse events: evidence from a systematic review of the literature.

Journal of the American Academy of Dermatology 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Establishment of murine basal cell carcinoma allografts: a potential model for preclinical drug testing and for molecular analysis.

The Journal of investigative dermatology 20111101

Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.

Journal of the European Academy of Dermatology and Venereology : JEADV 20111001

Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.

Journal of drugs in dermatology : JDD 20111001

Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation.

Journal of the American Academy of Dermatology 20110901

Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.

The American journal of pathology 20110901

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110801

Acitretin for the treatment of psoriasis: an assessment of national trends.

Journal of drugs in dermatology : JDD 20110801

Identification of ChIP-seq mapped targets of HP1β due to bombesin/GRP receptor activation.

Clinical epigenetics 20110801

Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.

Journal of drugs in dermatology : JDD 20110701

Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne.

Journal of drugs in dermatology : JDD 20110601

[Linear Darier disease].

Actas dermo-sifiliograficas 20110501

[A genome-wide screen for promoter-specific sites of differential DNA methylation during human cell malignant transformation in vitro].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 20110501

LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.

Leukemia 20110401

Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids.

Allergy, asthma & immunology research 20110401

Do lasers or topicals really work for nonmelanoma skin cancers?

Seminars in cutaneous medicine and surgery 20110301

Efficacy and safety study of tazarotene cream 0.1% for the treatment of brittle nail syndrome.

Cutis 20110201

Amyloidosis cutis dyschromica in two female siblings: cases report.

BMC dermatology 20110101

Bullous-hemorrhagic Darier disease.

Skinmed 20110101

Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review.

BMC medical research methodology 20110101

Acne vulgaris treatment : the current scenario.

Indian journal of dermatology 20110101

Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: an observer-blinded randomized controlled study.

Indian journal of dermatology 20110101

G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells.

BMC cancer 20110101

Differential effects of calorie restriction and exercise on the adipose transcriptome in diet-induced obese mice.

Journal of obesity 20110101

Management strategies for acne vulgaris.

Clinical, cosmetic and investigational dermatology 20110101

Comparative therapeutic evaluation of different topicals and narrow band ultraviolet B therapy combined with systemic methotrexate in the treatment of palmoplantar psoriasis.

Indian journal of dermatology 20110101

Keratin 13 is a more specific marker of conjunctival epithelium than keratin 19.

Molecular vision 20110101

Retinoid plus antimicrobial combination treatments for acne.

Clinical, cosmetic and investigational dermatology 20110101

Psoriasis in children: an insight.

Indian journal of dermatology 20110101

TIG3 tumor suppressor-dependent organelle redistribution and apoptosis in skin cancer cells.

PloS one 20110101

Quality of online pharmacies and websites selling prescription drugs: a systematic review.

Journal of medical Internet research 20110101

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.

PloS one 20110101

Biologicals and fetal cell therapy for wound and scar management.

ISRN dermatology 20110101

Improving the isotretinoin photostability by incorporating in microemulsion matrix.

ISRN pharmaceutics 20110101

Topical retinoids in the management of photodamaged skin: from theory to evidence-based practical approach.

The British journal of dermatology 20101201

[Retinoids: mechanisms of action].

Annales de dermatologie et de venereologie 20101101

Two-photon fluorescence excitation microscopy to assess transscleral diffusional pathways in an isolated perfused bovine eye model.

Investigative ophthalmology & visual science 20101001

Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer.

British journal of cancer 20100824

Topical tazarotene cream (0.1%) in the treatment of facial acne: an open clinical trial.

Bangladesh Medical Research Council bulletin 20100801

Topical tazarotene vs. coal tar in stable plaque psoriasis.

Clinical and experimental dermatology 20100701

Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Current oncology (Toronto, Ont.) 20100701

Stability-indicating chemometric methods for the determination of tazarotene.

Drug testing and analysis 20100701

Rapid improvement in digital ischemia and acral contracture in a collodion baby treated with topical tazarotene.

Journal of drugs in dermatology : JDD 20100601

Combination therapy with imiquimod, 5-fluorouracil, and tazarotene in the treatment of extensive radiation-induced Bowen's disease of the hands.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20100501

Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.

Journal of drugs in dermatology : JDD 20100501

Gene expression profiling in the lung tissue of cynomolgus monkeys in response to repeated exposure to welding fumes.

Archives of toxicology 20100301

Topical treatments for chronic plaque psoriasis.

American family physician 20100301

[Topical retinoids in acne--an evidence-based overview].

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20100301

Stability-indicating spectrophotometric methods for determination of tazarotene in the presence of its alkaline degradation product by derivative spectrophotometric techniques.

Drug testing and analysis 20100301

[Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].

Annales de dermatologie et de venereologie 20100101

Candidate genes for alcohol preference identified by expression profiling in alcohol-preferring and -nonpreferring reciprocal congenic rats.

Genome biology 20100101

Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery.

International journal of nanomedicine 20100101

Revealing new mouse epicardial cell markers through transcriptomics.

PloS one 20100101

Problems in the reporting of acne clinical trials: a spot check from the 2009 Annual Evidence Update on Acne Vulgaris.

Trials 20100101

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients.

Molecular cancer 20100101

[Redistribution of gastrointestinal ammonia into blood in alcohol coma rat: the role in lethal outcome].

Patologicheskaia fiziologiia i eksperimental'naia terapiia 20100101

Nonmelanoma skin cancer in India: current scenario.

Indian journal of dermatology 20100101

Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Clinical, cosmetic and investigational dermatology 20100101

Microencapsulation: A promising technique for controlled drug delivery.

Research in pharmaceutical sciences 20100101

Childhood psoriasis: often favorable outcome.

Prescrire international 20091201

Decomposition of gene expression state space trajectories.

PLoS computational biology 20091201

Role of the RARRES1 gene in nasopharyngeal carcinoma.

Cancer genetics and cytogenetics 20091001

Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris.

Journal of drugs in dermatology : JDD 20090701

Treatment in advanced colorectal cancer: what, when and how?

British journal of cancer 20090602

Managing toxicities and optimal dosing of targeted drugs in advanced kidney cancer.

Current oncology (Toronto, Ont.) 20090501

[Topical treatments for psoriasis in 2009].

Revue medicale suisse 20090422

Topical treatments for chronic plaque psoriasis.

The Cochrane database of systematic reviews 20090415

Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.

Journal of the American Academy of Dermatology 20090401

[Update of the topical treatment of psoriasis].

Actas dermo-sifiliograficas 20090401

Mimicry illuminating pitfalls in histopathologic diagnosis: nutritional deficiency-like dermatitis secondary to topical tazarotene and keratoacanthomatous pseudocarcinomatous hyperplasia in CD30+ lymphoproliferative disorder as illustrative.

The American Journal of dermatopathology 20090201

[Effects of all-trans retinioic acid and tazarotene on MMP-1 and TIMP-1 expression in cultured human fibroblasts after heat shock].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20090201

Changing the face of acne therapy.

Cutis 20090201

Efficacy and safety of topical tazarotene: a review.

Expert opinion on drug metabolism & toxicology 20090201

Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.

Bioorganic & medicinal chemistry letters 20090115

Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytes.

BMC microbiology 20090101

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations.

Current oncology (Toronto, Ont.) 20090101

Induction of apoptosis by the retinoid inducible growth regulator RIG1 depends on the NC motif in HtTA cervical cancer cells.

BMC cell biology 20090101

Psoriasis (chronic plaque).

BMJ clinical evidence 20090101

Impact on facial rejuvenation with dermatological preparations.

Clinical interventions in aging 20090101

The adult boar testicular and epididymal transcriptomes.

BMC genomics 20090101

Practice of phototherapy in the treatment of moderate-to-severe psoriasis.

Current problems in dermatology 20090101

New insights into molecular pathways associated with flatfish ovarian development and atresia revealed by transcriptional analysis.

BMC genomics 20090101

New and experimental skin-directed therapies for cutaneous lymphomas.

Skin pharmacology and physiology 20090101

Repeated mechanical trauma to the hands: the use of anti-impaction gloves for treatment and return to work.

Dermatitis : contact, atopic, occupational, drug 20090101

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.

Journal of translational medicine 20090101

Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: two case reports and a review of the literature.

Journal of medical case reports 20090101

Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects.

Molecular cancer 20090101

Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals.

PloS one 20090101

Pediatric psoriasis: an update.

Therapeutics and clinical risk management 20090101

Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis.

Genome biology 20090101

Attitudes of dermatologists in the southeastern United States regarding treatment of alopecia areata: a cross-sectional survey study.

BMC dermatology 20090101

Feature selection and classification of MAQC-II breast cancer and multiple myeloma microarray gene expression data.

PloS one 20090101

Microarray analysis of retinal gene expression in Egr-1 knockout mice.

Molecular vision 20090101

Elephantiasis nostras verrucosa: successful surgical treatment in a gross deformity.

Indian journal of dermatology 20090101

Bowenoid papulosis of the genitalia successfully treated with topical tazarotene: a report of two cases.

Indian journal of dermatology 20090101

Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.

OncoTargets and therapy 20090101

Rational use of cetuximab in the treatment of advanced non-small cell lung cancer.

OncoTargets and therapy 20090101

An update on the management of acne vulgaris.

Clinical, cosmetic and investigational dermatology 20090101

Biologics in the management of psoriasis.

Clinical, cosmetic and investigational dermatology 20090101

Topical retinoids in acne--an evidence-based overview.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20081201

Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib.

Annals of oncology : official journal of the European Society for Medical Oncology 20081101

Photocarcinogenesis of topical tazarotene and isotretinoin alone and in combination with valproic acid in hairless mice.

Experimental dermatology 20081101

[Alteration of tazarotene induced gene-2 expression in psoriasis vulgaris].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20081001

Effects of narrow-band ultraviolet B and tazarotene therapy on keratinocyte proliferation and TIG3 expression.

The Journal of dermatology 20081001

Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction.

Journal of drugs in dermatology : JDD 20080601

Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.

Journal of drugs in dermatology : JDD 20080601

Is switching retinoids a sound strategy for the treatment of acne vulgaris?

Journal of drugs in dermatology : JDD 20080601

Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.

Journal of drugs in dermatology : JDD 20080601

Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.

Molecular cancer therapeutics 20080501

A review of tazarotene in the treatment of photodamaged skin.

Clinical interventions in aging 20080301

Impurities of tazarotene: isolation and structural characterisation.

Journal of pharmaceutical and biomedical analysis 20080213

A case report of Hailey-Hailey disease treated with alefacept (Amevive).

The British journal of dermatology 20080201

Treatment of lentigo maligna with imiquimod before staged excision.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20080201

Effects of topically applied acitretin in reconstructed human epidermis and the rhino mouse.

The Journal of investigative dermatology 20080101

Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment.

Pediatric dermatology 20080101

Identification of a novel retinoid by small molecule screening with zebrafish embryos.

PloS one 20080101

Replicative senescence of mesenchymal stem cells: a continuous and organized process.

PloS one 20080101

Characterization of global transcription profile of normal and HPV-immortalized keratinocytes and their response to TNF treatment.

BMC medical genomics 20080101

Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy.

European journal of dermatology : EJD 20080101

Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas.

Clinics in dermatology 20080101

Transcriptional response of Mexican axolotls to Ambystoma tigrinum virus (ATV) infection.

BMC genomics 20080101

Cosmeceuticals: focus on topical retinoids in photoaging.

Clinics in dermatology 20080101

Downregulation of tazarotene induced gene-2 (TIG2) in skin squamous cell carcinoma.

European journal of dermatology : EJD 20080101

Topical retinoids in acne vulgaris: update on efficacy and safety.

American journal of clinical dermatology 20080101

A Web-based and Grid-enabled dChip version for the analysis of large sets of gene expression data.

BMC bioinformatics 20080101

Comparative study of calcipotriol (0.005%) ointment and tazarotene (0.05% and 0.1%) gel in the treatment of stable plaque psoriasis.

Indian journal of dermatology, venereology and leprology 20080101

Psoriasis disappearance after the first phase of an oncologic treatment: a serendipity case report.

La Clinica terapeutica 20080101

Wrinkles.

BMJ clinical evidence 20080101

Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071201

Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat.

Biologics : targets & therapy 20071201

Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption.

Journal of the American Academy of Dermatology 20071101

Chronically painful right thumb with pustules and onycholysis. Diagnosis: acrodermatitis continua of Hallopeau.

Clinical and experimental dermatology 20070901

[Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20070901

Tazarotene-induced irritation causing vitiligo by Koebnerization.

Journal of the European Academy of Dermatology and Venereology : JEADV 20070801

Treatment of locally metastatic melanoma: a novel approach.

Journal of drugs in dermatology : JDD 20070801

A review of the use of adapalene for the treatment of acne vulgaris.

Therapeutics and clinical risk management 20070801

Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.

Dermatology online journal 20070713

Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.

Journal of the American Academy of Dermatology 20070701

German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).

Archives of dermatological research 20070601

Successful treatment of Favre-Racouchot disease with 0.05% tazarotene gel.

Archives of dermatology 20070601

Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin.

Journal of drugs in dermatology : JDD 20070601

Progesterone regulation of implantation-related genes: new insights into the role of oestrogen.

Cellular and molecular life sciences : CMLS 20070401

Disseminated superficial actinic porokeratosis of the scalp.

Clinical and experimental dermatology 20070301

Palliative treatment of fingernail lichen planus.

Journal of drugs in dermatology : JDD 20070201

Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas.

International journal of dermatology 20070101

Supervised group Lasso with applications to microarray data analysis.

BMC bioinformatics 20070101

Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study.

Indian journal of dermatology, venereology and leprology 20070101

New lesions on the knees with palmoplantar keratoderma.

Cutis 20070101

Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.

Acta dermato-venereologica 20070101

Pharmacological treatments for basal cell carcinoma.

Drugs 20070101

Effect of tazarotene on ichthyosiform erythroderma of Tay's syndrome.

Indian journal of dermatology, venereology and leprology 20070101

Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.

Pediatric dermatology 20070101

Heteroarotinoids with anti-cancer activity against ovarian cancer cells.

The open medicinal chemistry journal 20070101

Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease.

Hereditary cancer in clinical practice 20070101

Etanercept in psoriasis: the evidence of its therapeutic impact.

Core evidence 20070101

Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.

Clinical interventions in aging 20061201

Lamellar ichthyosis treated with tazarotene 0.1% gel.

Journal of the American Academy of Dermatology 20061101

Tazarotene 0.1 percent cream fares better than erbium:YAG laser or incision and drainage in a patient with eruptive vellus hair cysts.

Dermatology online journal 20061031

Schools of pharmacology: retinoid update.

Journal of drugs in dermatology : JDD 20061001

Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.

Endocrine-related cancer 20060901

Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 20060901

[Elastosis perforans serpiginosa in a patient with pseudoxanthoma elasticum].

Actas dermo-sifiliograficas 20060901

[Inhibition of promyelocytic leukemia gene by tazarotene in hyperproliferative epidermis of psoriasis].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20060801

Combination topical therapy in the treatment of acne.

Cutis 20060801

Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.

Cutis 20060801

Chronic plaque psoriasis.

Clinical evidence 20060601

Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.

Archives of dermatology 20060501

A distinct molecular profile associated with mucinous epithelial ovarian cancer.

British journal of cancer 20060327

Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.

Journal of drugs in dermatology : JDD 20060301

Skin treatments and dermatological procedures to promote youthful skin.

Clinical interventions in aging 20060301

Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARalpha and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways.

Journal of cellular biochemistry 20060201

[From the Cochrane Library: Improvement of photodamaged skin with retinoid creams and not with other local treatments].

Nederlands tijdschrift voor geneeskunde 20060121

Linear Darier's disease successfully treated with 0.1% tazarotene gel 'short-contact' therapy.

European journal of dermatology : EJD 20060101

Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.

Cutis 20060101

Ichthyosis bullosa of Siemens: response to topical tazarotene.

Indian journal of dermatology, venereology and leprology 20060101

[Topical tazarotene for severe congenital ichthyosis].

Annales de dermatologie et de venereologie 20060101

Short contact therapy with tazarotene in psoriasis vulgaris.

Dermatology (Basel, Switzerland) 20060101

Receptor-selective retinoids for psoriasis: focus on tazarotene.

American journal of clinical dermatology 20060101

Management of refractory early-stage cutaneous T-cell lymphoma.

American journal of clinical dermatology 20060101

Quality of life in patients with psoriasis.

Health and quality of life outcomes 20060101

Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.

BMC cardiovascular disorders 20060101

Computational expression deconvolution in a complex mammalian organ.

BMC bioinformatics 20060101

Comparison of growth-inhibitory agents by fluorescence imaging of human skin re-epithelialization in vitro.

Acta dermato-venereologica 20060101

Erythrokeratoderma variabilis successfully treated with topical tazarotene.

Pediatric dermatology 20060101

Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.

Skinmed 20060101

Confluent and reticulated papillomatosis : a review of the literature.

American journal of clinical dermatology 20060101

Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology.

Dermatologic therapy 20060101

Retinoid therapy of pigmentary disorders.

Dermatologic therapy 20060101

The use of retinoids in the treatment of photoaging.

Dermatologic therapy 20060101

Ligand-based approach to in silico pharmacology: nuclear receptor profiling.

Journal of chemical information and modeling 20060101

Heterogeneity of mammary lesions represent molecular differences.

BMC cancer 20060101

Successful treatment of inflammatory linear verrucous epidermal nevus with tacrolimus and fluocinonide.

Journal of cutaneous medicine and surgery 20060101

Treatment of childhood psoriasis.

Acta dermatovenerologica Croatica : ADC 20060101

Wrinkles.

Clinical evidence 20051201

Disposition and biotransformation of the acetylenic retinoid tazarotene in humans.

Journal of pharmaceutical sciences 20051001

[Effects of all-trans-retinoic acid, acitretin and tazarotene on apoptosis and Bax/Bcl-2 expressions of human melanoma cells A375 and the significance].

Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050801

Corticosteroids: options in the era of steroid-sparing therapy.

Journal of the American Academy of Dermatology 20050701

A clinician's paradigm in the treatment of psoriasis.

Journal of the American Academy of Dermatology 20050701

Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging.

Cutis 20050701

A pilot study on the use of topical tazarotene to treat squamous cell carcinoma in situ.

Journal of the American Academy of Dermatology 20050601

Prediction of genotoxicity of chemical compounds by statistical learning methods.

Chemical research in toxicology 20050601

Topical retinoids in the treatment of photoaging.

Journal of cosmetic dermatology 20050601

Treatment of trachyonychia with tazarotene.

Clinical and experimental dermatology 20050501

Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%.

Cutis 20050501

Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies.

The Journal of dermatological treatment 20050401

The potential immunomodulatory effects of topical retinoids.

Dermatology online journal 20050301

The use of topical retinoids for inflammatory acne: a review of the pharmacoeconomic considerations.

Managed care interface 20050301

Potential future therapies for psoriasis.

Seminars in cutaneous medicine and surgery 20050301

A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.

Journal of the American Academy of Dermatology 20050201

Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20050201

An update on the safety and efficacy of topical retinoids.

Cutis 20050201

Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.

Clinical therapeutics 20050201

Interventions for photodamaged skin.

The Cochrane database of systematic reviews 20050125

Advances in therapy for psoriasis: an overview of infliximab, etanercept, efalizumab, alefacept, adalimumab, tazarotene, and pimecrolimus.

Current pharmaceutical design 20050101

Retinoid therapy for acne. A comparative review.

American journal of clinical dermatology 20050101

Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids.

Journal of drugs in dermatology : JDD 20050101

Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.

Journal of drugs in dermatology : JDD 20050101

Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis.

Journal of drugs in dermatology : JDD 20050101

The role of topical retinoids in the treatment of photoaging.

Drugs 20050101

The protective role of pregnancy in breast cancer.

Breast cancer research : BCR 20050101

Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis.

Acta dermato-venereologica 20050101

Topical tazarotene: a review of its use in the treatment of plaque psoriasis.

American journal of clinical dermatology 20050101

Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene.

Acta dermato-venereologica 20050101

Effects of ATRA, acitretin and tazarotene on growth and apoptosis of Tca8113 cells.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20050101

Topical halobetasol propionate in the treatment of plaque psoriasis: a review.

American journal of clinical dermatology 20050101

Comedolytic effect of a novel RARgamma-specific retinoid, ER36009: comparison with retinoic acid in the rhino mouse model.

European journal of dermatology : EJD 20050101

An evaluation of the efficacy and safety of tazarotene (0.1%) cream in acne vulgaris.

Indian journal of dermatology, venereology and leprology 20050101

A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation.

Molecular pharmacology 20041201

Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin.

The British journal of dermatology 20041201

The p73 gene is an anti-tumoral target of the RARbeta/gamma-selective retinoid tazarotene.

The Journal of investigative dermatology 20041201

Wrinkles.

Clinical evidence 20041201

Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma.

British journal of cancer 20041101

Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.

Clinical therapeutics 20041101

Retinoid therapy for psoriasis.

Dermatologic clinics 20041001

Topical retinoids in the management of acne: the best path to clear results.

Cutis 20041001

Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.

Cutis 20041001

Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.

Cutis 20041001

Topical tazarotene in acne vulgaris: treatment approaches.

Cutis 20041001

Keratosis punctata palmoplantaris controlled with topical retinoids: a case report and review of the literature.

Cutis 20040901

Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation.

Cancer research 20040701

Questions & answers. Of all the treatments that promise to improve the appearance of aging skin, which ones have been medically proven to actually work?

Health news (Waltham, Mass.) 20040701

Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases.

The British journal of dermatology 20040701

Established treatments of psoriasis.

Current drug targets. Inflammation and allergy 20040601

Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 20040601

Chronic plaque psoriasis.

Clinical evidence 20040601

Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.

Journal of the American Academy of Dermatology 20040401

Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod.

International journal of dermatology 20040401

Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene.

The Journal of investigative dermatology 20040401

Tazarotene 0.1% cream for the treatment of photodamage.

Skin therapy letter 20040401

[Prescribe topical treatments for psoriasis].

La Revue du praticien 20040115

Treatment of lentigo maligna with tazarotene 0.1% gel.

Journal of the American Academy of Dermatology 20040101

Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.

Skin pharmacology and physiology 20040101

Oral tazarotene and oral pimecrolimus: novel oral therapies in development for psoriasis.

Journal of drugs in dermatology : JDD 20040101

Topical retinoid and antibiotic combination therapy for acne management.

Journal of drugs in dermatology : JDD 20040101

Adapalene: a review of its use in the treatment of acne vulgaris.

Drugs 20040101

Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive.

Clinical pharmacokinetics 20040101

Current management strategies for cutaneous T-cell lymphoma.

Clinics in dermatology 20040101

Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene.

Journal of drugs in dermatology : JDD 20040101

Spotlight on adapalene in acne vulgaris.

American journal of clinical dermatology 20040101

Comparison of topical retinoids in the treatment of acne.

Clinics in dermatology 20040101

Facial tolerability of topical retinoid therapy.

Journal of drugs in dermatology : JDD 20040101

Treatment of Nevus comedonicus with topical tazarotene and calcipotriene.

Journal of drugs in dermatology : JDD 20040101

An open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acne vulgaris.

Indian journal of dermatology, venereology and leprology 20040101

Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23.

FEBS letters 20031218

The efficacy of topical tazarotene monotherapy and combination therapies in psoriasis.

Expert opinion on pharmacotherapy 20031201

Wrinkles.

Clinical evidence 20031201

[Medication of the month. Tazarotene 0.05%-0.1% (Zorac)].

Revue medicale de Liege 20031101

Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents.

British journal of cancer 20031006

Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application.

The Journal of investigative dermatology 20031001

[Treatment options in monogenic disorders of keratinization].

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20031001

[Porokeratotic eccrine ostial and dermal duct naevus (PEODDN)].

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20031001

A phase 1 study of tazarotene in adults with advanced cancer.

British journal of cancer 20030901

Investigational therapies for psoriasis.

Journal of the American Academy of Dermatology 20030801

Type I lamellar ichthyosis improved by tazarotene 0.1% gel.

Clinical and experimental dermatology 20030701

Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.

Cutis 20030701

Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study.

The British journal of dermatology 20030701

Confluent and reticulated papillomatosis: response to tazarotene.

Journal of the American Academy of Dermatology 20030501

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.

Journal of the American Academy of Dermatology 20030501

Cytochrome P450 2C8 and flavin-containing monooxygenases are involved in the metabolism of tazarotenic acid in humans.

Drug metabolism and disposition: the biological fate of chemicals 20030401

Acne cream can reverse sun damage.

Health news (Waltham, Mass.) 20030201

A systematic review of adverse effects associated with topical treatments for psoriasis.

Dermatology online journal 20030201

Management of acne.

The Journal of family practice 20030101

The rationale for using a topical retinoid for inflammatory acne.

American journal of clinical dermatology 20030101

Optimizing treatment with topical tazarotene.

American journal of clinical dermatology 20030101

The topical treatment of psoriasis.

Skin pharmacology and applied skin physiology 20030101

Short-contact therapy with tazarotene in psoriasis vulgaris.

Dermatology (Basel, Switzerland) 20030101

Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.

Clinical pharmacokinetics 20030101

Treatment of occupational koilonychia with tazarotene gel.

Acta dermato-venereologica 20030101

Retrospective analysis of the treatment of psoriasis of the palms and soles.

The Journal of dermatological treatment 20030101

Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.

Archives of dermatology 20021101

Questionable techniques for evaluating photodamage.

Archives of dermatology 20021101

Oral lichen planus: a preliminary clinical study on treatment with tazarotene.

Oral diseases 20021101

[Immunosuppresive agents, retinoids and new trends in the therapy of psoriasis].

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20021101

A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.

The British journal of dermatology 20021001

[Psoriatic onycho-pachydermo- periostitis].

Zeitschrift fur Rheumatologie 20021001

Treating keratosis pilaris.

Journal of the American Academy of Dermatology 20020901

Tazarotene (tazorac) for acne.

The Medical letter on drugs and therapeutics 20020610

Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.

Journal of the American Academy of Dermatology 20020601

Refining retinoids with heteroatoms.

Mini reviews in medicinal chemistry 20020601

Instrumental evaluation of retinoid-induced skin irritation.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 20020501

Is TIG1 a new tumor suppressor in prostate cancer?

Journal of the National Cancer Institute 20020403

Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel.

Archives of dermatology 20020401

Topical tazarotene therapy for psoriasis, acne vulgaris, and photoaging.

Skin therapy letter 20020301

Treatment of warty dyskeratoma with tazarotenic acid.

Journal of the American Academy of Dermatology 20020201

Tazarotene is an effective therapy for elastosis perforans serpiginosa.

Archives of dermatology 20020201

Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.

Cutis 20020201

Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.

Cutis 20020201

A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.

Cutis 20020201

Topical agents for the treatment of psoriasis, past, present and future.

Journal of cutaneous medicine and surgery 20020101

Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies.

Journal of cutaneous medicine and surgery 20020101

Treatment of cutaneous T cell lymphoma: current status and future directions.

American journal of clinical dermatology 20020101

A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.

Journal of cutaneous medicine and surgery 20020101

Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20020101

Potential anti-inflammatory effects of topical retinoids and retinoid analogues.

Advances in therapy 20020101

Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.

Drugs & aging 20020101

Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.

Archives of dermatology 20011201

The efficacy of 308nm laser treatment of psoriasis compared to historical controls.

Dermatology online journal 20011201

Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study.

Cutis 20011101

Treatment of psoriasis. Part 1. Topical therapy and phototherapy.

Journal of the American Academy of Dermatology 20011001

Developments in topical retinoid therapy for acne.

Seminars in cutaneous medicine and surgery 20010901

A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.

International journal of dermatology 20010701

[Successful symptomatic tazarotene treatment of juvenile acanthosis nigricans of the familial obesity-associated type in insulin resistance].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20010601

Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.

Cutis 20010601

Randomized facial tolerability studies comparing gel formulations of retinoids used to treat acne vulgaris.

Cutis 20010601

Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.

Cutis 20010601

Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis.

The Journal of investigative dermatology 20010501

1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects.

Breast cancer research and treatment 20010501

Retinoids for the treatment of psoriasis: outlook for the future.

Current opinion in investigational drugs (London, England : 2000) 20010501

Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis.

International journal of dermatology 20010301

Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.

Cutis 20010201

Focal acral hyperkeratosis.

Dermatology online journal 20010201

Duration of improvement in psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: comparison of maintenance treatments.

International journal of dermatology 20010101

New developments in the treatment of psoriasis.

Skin pharmacology and applied skin physiology 20010101

The modern age of acne therapy: a review of current treatment options.

The Mount Sinai journal of medicine, New York 20010101

Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment.

Drugs 20010101

Retinoids--which dermatological indications will benefit in the near future?

Skin pharmacology and applied skin physiology 20010101

Tazarotene: a review of its pharmacological profile and potential for clinical use in psoriasis.

Expert opinion on investigational drugs 19971001